This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Anti-microbial/Anti-fungal Tests Market

Discover with FMI How Anti-microbial/Anti-fungal Tests are Gaining Traction Amond Patients with Fungal Infections!

Anti-microbial/Anti-fungal Tests Market by Tests, Infection, End User & Region - Forecast 2022 - 2032

Anti-microbial/Anti-fungal Tests Market Outlook (2022-2032)

[268 Pages Report] The global anti-microbial/anti-fungal tests market is expected to reach US$ 2.5 Bn by the end of 2022. Growth in the market is predicted to expand at a CAGR rate of 5.7% and surpass ~US$ 4.5 Bn by 2032. Based on tests type, the molecular-based tests led the market with a share of nearly 53.5% in 2021.

Attributes

Key Insights

Anti-microbial/Anti-fungal Tests Market Value 2021

US$ 2.4 Bn

Estimated Market Size 2022

US$ 2.5 Bn

Projected Market Value 2032

US$ 4.5 Bn

CAGR 2022-2032

5.7%

Market Share of Top 5 Countries

55.0%

Microorganism screening to create novel antibiotics has been successfully pursued for numerous years by the researcher. Fungus and bacteria often generate antibiotics. Bacteria are consumed in a variety of fields, including agriculture. In the pharmaceutical and veterinary industries, an antimicrobial is a substance that kills or inhibits bacterial growth.

Antibiotics are employed against antifungals, and bacteria are utilized against fungi in these cases. Antimicrobial chemotherapeutic uses antimicrobial drugs to combat infection, and antimicrobial prophylaxis uses antimicrobial medicines to prevent infection. Antimicrobial susceptibility tests can help physicians choose the best medicine and dosage for difficult-to-treat infections.

Customize this Report

Let us know your requirement to get
100% FREE customization

Sales Analysis of Anti-microbial/Anti-fungal Tests Market from 2012 to 2021 Vs Demand Outlook for 2022 to 2032

As per Future Market Insights (FMI), the anti-microbial/anti-fungal tests market was approximately 15.4% of the overall ~US$ 15.6 Bn global rapid testing kits market in 2021. Overall sales in the anti-microbial/anti-fungal tests market surged at a CAGR of 5.6% from 2012 to 2021.

Growth in the market is primarily attributed to the increased prevalence of infectious diseases across the globe. Furthermore, rising rates of surgical site infections and other related issues are propelling the sales in the antimicrobial antifungal test market. Further, advancements in biotechnology and in diagnostic procedures is facilitating the growth in the market.

As a number of pathogenic bacteria develop antibiotic resistance and novel forms of resistance emerge, healthcare professionals are focusing on antimicrobial susceptibility testing (AST). Minimum inhibitory concentrations (MICs) are provided by a rapid multiplexed AST platform at a reasonable cost, allowing for the rapid determination of effective targeted therapy. This is resulting in shorter hospital stays, fewer laboratory tests, and lower morbidity and mortality, as well as associated healthcare costs.

Furthermore, the market witnessed prolific growth as the use of antibiotic and antifungal skyrocketed. Further, nosocomial bacterial superinfections are more common than community-acquired coinfections. This is particularly among ICU patients and those taking immunosuppressive therapy. On the back of these factors, the global anti-microbial/anti-fungal tests market is expected to grow at a CAGR of 5.7% during the forecast period.

Anti-microbial/Anti-fungal Tests Market Download Report Brochure

What are the Key Opportunities in the Anti-microbial/Anti-fungal Tests Kit Market?

  • Favorable Government Initiatives and Awareness Programs to Fuel the Growth

Favorable government initiatives and development of healthcare infrastructure across the globe is the key factor propelling the sales in the global anti-microbial/anti-fungal tests kit market. Advancements in point-of-care (POC) detection methods that enable decentralised, quick, sensitive, low-cost COVID-19 infection diagnostics are spuuring the growth in the market.

Furthermore, rising awareness by government bodies has positively impacted manufacturers and healthcare service providers. For instance, WAAW was formerly known as World Antibiotic Awareness Week, which is now changed to World Antimicrobial Awareness Week in 2020. This reflects WAAW's expanded scope, which now includes all antimicrobials such as antifungals, antibiotics, antiparasitics, and antivirals.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What are the Factors Restraining Demand for Anti-microbial/Anti-fungal Tests?

The lack of an innovation culture and stringent regulatory approvals might hamper the demand in the market. In general, healthcare providers and medical workers are risk-averse and resistant to policy reforms. In the realm of in-vitro diagnostics, there have been numerous instances where physicians have been highly reluctant to advance. Furthermore, the administration and organization of diagnostic services may further restrict the market in the forecast period's coming years.

Further, the complexity in interpreting the paradoxical growth phenomenon seen with echinocandins and yeasts (which differs from the trailing effect) and uncertainty for caspofungin testing is due to the molecule's lack of stability in culture media. These factors cumulatively might negatively affect the growth in the anti-microbial/anti-fungal tests market.

Country-wise Insights

How will the Sales in the U.S. Anti-microbial/Anti-fungal Tests Market Increase?

Growing Preference for Diagnostic Tests to Boost the Sales

The U.S. dominated the North America anti-micorbial/anti-fungal tests market with a total share of about 89.4% in 2021. Growth in the market is primarily underpinned by growing preference for diagnostic tests recommended by physicians before any type of treatment. Furthermore, widespread awareness of the adverse effects of particular medications, and patients frequently prefer to be fully diagnosed before seeking treatment.

Will China Retain its Dominance in Anti-microbial/Anti-fungal Tests Market?

Rising Prevalence of NIC and Diabetes Mellitus to Facilitate the Growth in China

China held approximately 7.5% share in the global anti-microbial/anti-fungal tests market in 2021, as per FMI. Sales in the market are projected to display growth at a CAGR of 7.1% during the forecast period.

Due to the increased number of immunocompromised individuals, invasive fungal infections (IFIs), especially those caused by uncommon yeasts, are becoming more common. Invasive candidiasis is the key concern with significant morbidity and mortality.

It affects patients of all ages, including those with malignancies, non-immunocompromised (NIC) and HIV-negative immunocompromised (IC) patients, individuals among the severely ill, typically hospitalised to an intensive care unit (ICU), or diagnosed with diabetes mellitus or uncontrolled hyperglycaemia needing invasive mechanical ventilation.

How Big is the Opportunity in Germany Anti-microbial/Anti-fungal Tests Market?

Germany Anti-microbial/Anti-fungal Tests Market to Gain from Rising Incidence of Fungal Infection

Germany is set to exhibit a CAGR growth of nearly 7.1% in the Europe anti-microbial/anti-fungal tests market during the forecast period. Candida glabrata is the second most common fungal infection in Germany, causing candidaemia and invasive candidiasis.

This yeast is known for its quick acquisition of antifungal medication resistance. Furthermore, with the increasing prevalence of chronic and infectious diseases, the ageing population will demand the anti-microbial/anti-fungal tests market.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Category-wise Insights

Which Anti-microbial/Anti-fungal Tests Type is Driving the Growth?

Molecular Based Tests to Gain Immense Traction through 2022 & Beyond

Molecular-based tests are expected to lead the market, registering growth at a CAGR of 5.3% during the forecast period. The segment is expecetd to account for a share of more than 50.0% in the global anti-microbial/anti-fungal tests market. Owing to their factors of increasing susceptibility, minimization of false positive results, better turnaround time and possesses wide applications.

Based on infection, the antimicrobial resistance held revenue share of 48% in 2021 and is expected to display gradual growth over the forecast period. Antimicrobial resistance (AMR) emerges when fungi, viruses, bacteria, and parasites evolve over a period. Therefore it shows no longer responds to the antibiotics treatment, making infections more challenging to treat and increasing the risk of disease spread, major illness, and death. This is expected to fuel revenue growth over the forecast period.

Which is the Leading End User in Anti-microbial/Anti-fungal Tests Market?

Nearly 2 out of 5 Sales to be Contributed by Hospitals

As per FMI, hospitals held the market with the highest share value of 36.9% and are expected to maintain the lead over the upcoming decade. Increasing hospital-acquired infections and increasing inpatient admissions are propelling sales of the overall anti-microbial/anti-fungal tests market.

Competitive Landscape

With several competitors in the anti-microbial/anti-fungal tests market, the overall market is fragmented. To meet consumer demand and expand their customer base, these companies are implementing methods such as mergers and acquisitions, partnerships and collaborations, and new product launches.

  • In July 2022, Roche announced that Elecsys HCV Duo immunoassay is now available in countries that accept the CE Mark. Elecsys HCV Duo is the only immunoassay on the market that can determine hepatitis C virus (HCV) antigen and antibody status from a single human plasma or serum sample.
  • In June 2022, Meridian Bioscience, Inc., a global leader in diagnostic testing solutions and life science raw materials, introduced two new sample-specific master mixes, Lyo-Ready Direct DNA qPCR Stool Mix and Lyo-Ready Direct RNA/DNA qPCR Stool Mix. These novel master mixes increase the molecular detection of DNA and RNA from crude faecal materials while allowing diagnostic procedures to be room temperature stabilised.

Report Scope as per Anti-microbial/Anti-fungal Tests Industry Analysis

Attribute

Details

Estimated Market Size 2022

US$ 2.5 Bn

Projected Market Value 2032

US$ 4.5 Bn

CAGR 2022-2032

5.7%

Forecast Period

2012-2021

Historical Data Available for

2022-2032

Market Analysis

US$ Mn for Value

Key Regions Covered

North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa

Key Countries Covered

U.S., Canada, Brazil, Mexico, Argentina, U.K., Germany, Italy, Russia, Spain, France, BENELUX, Nordic Countries, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC, South Africa and North Africa

Key Market Segments Covered

Tests, Infection, End User, and Region

Key Companies Profiled

  • Abbott Laboratories
  • bioMérieux SA
  • Bio-Rad Laboratories Inc
  • Bruker Corporation
  • Danaher Corporation
  • Erba Mannheim
  • F. Hoffmann-La Roche AG
  • Luminex Corporation
  • Meridian Bioscience Inc
  • Norgen Biotek Corp
  • Omega Diagnostics Group Plc
  • Qiagen N.V
  • Quidel Corporation
  • Thermo Fisher Scientific Inc

Key Market Segments Covered in Anti-microbial/Anti-fungal Tests Industry Research

By Tests Type:

  • Molecular Based Tests
    • PCR Test
    • DNA Microarray
  • Phenotypic Resistance Tests
  • Complex Test Panels
  • Mass Spectrometry
  • Rapid Diagnostic Tests
    • E-Test Antibiotic/Antifungal Strips
    • Biosensor Platforms

By Infection Type:

  • Antimicrobial Resistance
    • Methicillin-Resistant Staphylococcus Aureus
    • Vancomycin-Resistant Enterococcus
    • Multi-Drug-Resistant Mycobacterium tuberculosis
    • Carbapenem-Resistant Enterobacteriaceae gut bacteria
  • Microbial Infection
  • Antifungal Resistance
    • Candida infections
    • Aspergillus infection
    • Fusariosis
    • Others
  • Fungal Infection

By End User:

  • Hospitals
  • Ambulatory Surgical Centers
  • Clinics
  • Community Health Centers
  • Reference Laboratories

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Frequently Asked Questions

The global anti-microbial/anti-fungal tests market is worth US$ 2.4 Bn in 2021 and is set to expand 1.7X over the next ten years.

The anti-microbial/anti-fungal tests market is expected to reach US$ 4.5 Bn by the end of 2032, with sales revenue expected to register a 5.7% CAGR.

The growing geriatric population and innovative product development, increasing prevalence of antimicrobial resistance cases are some of the key trends in this market.

U.S., India, China, Germany, and Japan are expected to drive demand for the anti-microbial/anti-fungal tests industry.

North America is one of the key markets for anti-microbial/anti-fungal tests, with the U.S. accounting for about 89.4% of the North American anti-microbial/anti-fungal tests market in the year 2021.

Demand for anti-microbial/anti-fungal tests in Europe is expected to register a growth of 5.0% CAGR over the next ten years.

Demand for anti-microbial/anti-fungal tests in MEA is expected to register a growth of 4.5% over the next ten years.

China and the U.S., Germany are the key producers of anti-microbial/anti-fungal tests.

Abbott Laboratories, bioMérieux SA, Bio-Rad Laboratories Inc., Bruker Corporation, Danaher Corporation, Erba Mannheim, F. Hoffmann-La Roche AG, Luminex Corporation, Meridian Bioscience Inc., Norgen Biotek Corp., Omega Diagnostics Group Plc., Qiagen N.V., Quidel Corporation, and Thermo Fisher Scientific Inc., are some of the key players in the anti-microbial/anti-fungal tests industry.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Key Success Factors

    4.1. Epidemiology of Key Indication, By Region

    4.2. Key Promotional Strategies

    4.3. Patient Journey

    4.4. Regulatory Scenario

    4.5. Reimbursement Landscape

    4.6. PESTEL analysis

    4.7. Porter’s analysis

    4.8. Value Chain

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP Growth Outlook

        5.1.2. Global Healthcare GDP Growth Overview

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Rising Prevalence of infectious diseases.

        5.2.2. Increasing Awareness and Adoption.

        5.2.3. Increase in rapid diagnostics tests.

        5.2.4. Increasing prevalence of antimicrobial resistance patients.

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

    5.4. Global Supply Demand Analysis

6. COVID-19 Crisis – Crisis Analysis

    6.1. COVID-19 and Impact Analysis

    6.2. 2021 Market Scenario

        6.2.1. By Tests Type

        6.2.2. By Infection Type

        6.2.3. By End User

        6.2.4. By Region

7. Global Anti-microbial/Anti-fungal Tests Market Demand (in Value or Size in US$ Mn) Analysis 2012-2021 and Forecast, 2022–2032

    7.1. Historical Market Value (US$ Mn) Analysis, 2012-2021

    7.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032

        7.2.1. Y-o-Y Growth Trend Analysis

        7.2.2. Absolute $ Opportunity Analysis

8. Global Anti-microbial/Anti-fungal Tests Market Analysis 2012-2021 and Forecast 2022–2032, By Tests Type

    8.1. Introduction / Key Findings

    8.2. Historical Market Size (US$ Mn) Analysis By Tests Type, 2012-2021

    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Tests Type, 2022–2032

        8.3.1. Molecular Based Tests

            8.3.1.1. PCR Test

            8.3.1.2. DNA Microarray

        8.3.2. Phenotypic Resistance Tests

        8.3.3. Complex Test Panels

        8.3.4. Mass Spectrometry

        8.3.5. Rapid Diagnostic Tests

            8.3.5.1. E-Test Antibiotic/Antifungal Strips

            8.3.5.2. Biosensor Platforms

    8.4. Market Attractiveness Analysis By Tests Type

9. Global Anti-microbial/Anti-fungal Tests Market Analysis 2012-2021 and Forecast 2022–2032, By Infection Type

    9.1. Introduction / Key Findings

    9.2. Historical Market Size (US$ Mn) Analysis, By Infection Type, 2012-2021

    9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Infection Type, 2022–2032

        9.3.1. Antimicrobial Resistance

            9.3.1.1. Methicillin-Resistant Staphylococcus Aureus

            9.3.1.2. Vancomycin-Resistant Enterococcus

            9.3.1.3. Multi-Drug-Resistant Mycobacterium tuberculosis

            9.3.1.4. Carbapenem-Resistant Enterobacteriaceae gut bacteria

        9.3.2. Microbial Infection

        9.3.3. Antifungal Resistance

            9.3.3.1. Candida infections

            9.3.3.2. Aspergillus infection

            9.3.3.3. Fusariosis

            9.3.3.4. Others

        9.3.4. Fungal Infection

    9.4. Market Attractiveness Analysis By Infection Type

10. Global Anti-microbial/Anti-fungal Tests Market Analysis 2012-2021 and Forecast 2022–2032, By End User

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) Analysis, By End User, 2012-2021

    10.3. Current and Future Market Size (US$ Mn) Analysis Forecast By End User, 2022–2032

        10.3.1. Hospitals

        10.3.2. Ambulatory Surgical Centers

        10.3.3. Clinics

        10.3.4. Community Health Centers

        10.3.5. Reference Laboratories

    10.4. Market Attractiveness Analysis By End User

11. Global Anti-microbial/Anti-fungal Tests Market Analysis 2012-2021 and Forecast 2022–2032, by Region

    11.1. Introduction

    11.2. Historical Market Size (US$ Mn) Analysis By Region, 2012-2021

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2022–2032

        11.3.1. North America

        11.3.2. Latin America

        11.3.3. Europe

        11.3.4. East Asia

        11.3.5. South Asia

        11.3.6. Oceania

        11.3.7. Middle East and Africa (MEA)

    11.4. Market Attractiveness Analysis By Region

12. North America Anti-microbial/Anti-fungal Tests Market Analysis 2012-2021 and Forecast 2022–2032

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) Analysis Trend Analysis By Market Taxonomy, 2012-2021

    12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032

        12.3.1. By Country

            12.3.1.1. U.S.

            12.3.1.2. Canada

        12.3.2. By Tests Type

        12.3.3. By Infection Type

        12.3.4. By End User

    12.4. Market Attractiveness Analysis

        12.4.1. By Country

        12.4.2. By Tests Type

        12.4.3. By Infection Type

        12.4.4. By End User

    12.5. Market Trends

    12.6. Key Market Participants - Intensity Mapping

    12.7. Drivers and Restraints - Impact Analysis

    12.8. Country Level Analysis & Forecast

        12.8.1. U.S. Anti-microbial/Anti-fungal Tests Market Analysis

            12.8.1.1. Introduction

            12.8.1.2. Market Analysis and Forecast by Market Taxonomy

                12.8.1.2.1. By Tests Type

                12.8.1.2.2. By Infection Type

                12.8.1.2.3. By End User

        12.8.2. Canada Anti-microbial/Anti-fungal Tests Market Analysis

            12.8.2.1. Introduction

            12.8.2.2. Market Analysis and Forecast by Market Taxonomy

                12.8.2.2.1. By Tests Type

                12.8.2.2.2. By Infection Type

                12.8.2.2.3. By End User

13. Latin America Anti-microbial/Anti-fungal Tests Market Analysis 2012-2021 and Forecast 2022–2032

    13.1. Introduction

    13.2. Historical Market Size (US$ Mn) Analysis Trend Analysis By Market Taxonomy, 2012-2021

    13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032

        13.3.1. By Country

            13.3.1.1. Mexico

            13.3.1.2. Brazil

            13.3.1.3. Argentina

            13.3.1.4. Rest of Latin America

        13.3.2. By Tests Type

        13.3.3. By Infection Type

        13.3.4. By End User

    13.4. Market Attractiveness Analysis

        13.4.1. By Country

        13.4.2. By Tests Type

        13.4.3. By Infection Type

        13.4.4. By End User

    13.5. Market Trends

    13.6. Key Market Participants - Intensity Mapping

    13.7. Drivers and Restraints - Impact Analysis

    13.8. Country Level Analysis & Forecast

        13.8.1. Mexico Anti-microbial/Anti-fungal Tests Market Analysis

            13.8.1.1. Introduction

            13.8.1.2. Market Analysis and Forecast by Market Taxonomy

                13.8.1.2.1. By Tests Type

                13.8.1.2.2. By Infection Type

                13.8.1.2.3. By End User

        13.8.2. Brazil Anti-microbial/Anti-fungal Tests Market Analysis

            13.8.2.1. Introduction

            13.8.2.2. Market Analysis and Forecast by Market Taxonomy

                13.8.2.2.1. By Tests Type

                13.8.2.2.2. By Infection Type

                13.8.2.2.3. By End User

        13.8.3. Argentina Anti-microbial/Anti-fungal Tests Market Analysis

            13.8.3.1. Introduction

            13.8.3.2. Market Analysis and Forecast by Market Taxonomy

                13.8.3.2.1. By Tests Type

                13.8.3.2.2. By Infection Type

                13.8.3.2.3. By End User

14. Europe Anti-microbial/Anti-fungal Tests Market Analysis 2012-2021 and Forecast 2022–2032

    14.1. Introduction

    14.2. Historical Market Size (US$ Mn) Analysis Trend Analysis By Market Taxonomy, 2012-2021

    14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032

        14.3.1. By Country

            14.3.1.1. Germany

            14.3.1.2. Italy

            14.3.1.3. France

            14.3.1.4. U.K.

            14.3.1.5. Spain

            14.3.1.6. BENELUX

            14.3.1.7. Russia

            14.3.1.8. Rest of Europe

        14.3.2. By Tests Type

        14.3.3. By Infection Type

        14.3.4. By End User

    14.4. Market Attractiveness Analysis

        14.4.1. By Country

        14.4.2. By Tests Type

        14.4.3. By Infection Type

        14.4.4. By End User

    14.5. Market Trends

    14.6. Key Market Participants - Intensity Mapping

    14.7. Drivers and Restraints - Impact Analysis

    14.8. Country Level Analysis & Forecast

        14.8.1. Germany Anti-microbial/Anti-fungal Tests Market Analysis

            14.8.1.1. Introduction

            14.8.1.2. Market Analysis and Forecast by Market Taxonomy

                14.8.1.2.1. By Tests Type

                14.8.1.2.2. By Infection Type

                14.8.1.2.3. By End User

        14.8.2. Italy Anti-microbial/Anti-fungal Tests Market Analysis

            14.8.2.1. Introduction

            14.8.2.2. Market Analysis and Forecast by Market Taxonomy

                14.8.2.2.1. By Tests Type

                14.8.2.2.2. By Infection Type

                14.8.2.2.3. By End User

        14.8.3. France Anti-microbial/Anti-fungal Tests Market Analysis

            14.8.3.1. Introduction

            14.8.3.2. Market Analysis and Forecast by Market Taxonomy

                14.8.3.2.1. By Tests Type

                14.8.3.2.2. By Infection Type

                14.8.3.2.3. By End User

        14.8.4. U.K. Anti-microbial/Anti-fungal Tests Market Analysis

            14.8.4.1. Introduction

            14.8.4.2. Market Analysis and Forecast by Market Taxonomy

                14.8.4.2.1. By Tests Type

                14.8.4.2.2. By Infection Type

                14.8.4.2.3. By End User

        14.8.5. Spain Anti-microbial/Anti-fungal Tests Market Analysis

            14.8.5.1. Introduction

            14.8.5.2. Market Analysis and Forecast by Market Taxonomy

                14.8.5.2.1. By Tests Type

                14.8.5.2.2. By Infection Type

                14.8.5.2.3. By End User

        14.8.6. BENELUX Anti-microbial/Anti-fungal Tests Market Analysis

            14.8.6.1. Introduction

            14.8.6.2. Market Analysis and Forecast by Market Taxonomy

                14.8.6.2.1. By Tests Type

                14.8.6.2.2. By Infection Type

                14.8.6.2.3. By End User

        14.8.7. Russia Anti-microbial/Anti-fungal Tests Market Analysis

            14.8.7.1. Introduction

            14.8.7.2. Market Analysis and Forecast by Market Taxonomy

                14.8.7.2.1. By Tests Type

                14.8.7.2.2. By Infection Type

                14.8.7.2.3. By End User

15. South Asia Anti-microbial/Anti-fungal Tests Market Analysis 2012-2021 and Forecast 2022–2032

    15.1. Introduction

    15.2. Historical Market Size (US$ Mn) Analysis Trend Analysis By Market Taxonomy, 2012-2021

    15.3. Current and Future Market Size (US$ Mn) Analysis Forecast By Market Taxonomy, 2022–2032

        15.3.1. By Country

            15.3.1.1. India

            15.3.1.2. Indonesia

            15.3.1.3. Malaysia

            15.3.1.4. Thailand

            15.3.1.5. Rest of South Asia

        15.3.2. By Tests Type

        15.3.3. By Infection Type

        15.3.4. By End User

    15.4. Market Attractiveness Analysis

        15.4.1. By Country

        15.4.2. By Tests Type

        15.4.3. By Infection Type

        15.4.4. By End User

    15.5. Market Trends

    15.6. Key Market Participants - Intensity Mapping

    15.7. Drivers and Restraints - Impact Analysis

    15.8. Country Level Analysis & Forecast

        15.8.1. India Anti-microbial/Anti-fungal Tests Market Analysis

            15.8.1.1. Introduction

            15.8.1.2. Market Analysis and Forecast by Market Taxonomy

                15.8.1.2.1. By Tests Type

                15.8.1.2.2. By Infection Type

                15.8.1.2.3. By End User

        15.8.2. Indonesia Anti-microbial/Anti-fungal Tests Market Analysis

            15.8.2.1. Introduction

            15.8.2.2. Market Analysis and Forecast by Market Taxonomy

                15.8.2.2.1. By Tests Type

                15.8.2.2.2. By Infection Type

                15.8.2.2.3. By End User

        15.8.3. Malaysia Anti-microbial/Anti-fungal Tests Market Analysis

            15.8.3.1. Introduction

            15.8.3.2. Market Analysis and Forecast by Market Taxonomy

                15.8.3.2.1. By Tests Type

                15.8.3.2.2. By Infection Type

                15.8.3.2.3. By End User

        15.8.4. Thailand Anti-microbial/Anti-fungal Tests Market Analysis

            15.8.4.1. Introduction

            15.8.4.2. Market Analysis and Forecast by Market Taxonomy

                15.8.4.2.1. By Tests Type

                15.8.4.2.2. By Infection Type

                15.8.4.2.3. By End User

16. East Asia Anti-microbial/Anti-fungal Tests Market Analysis 2012-2021 and Forecast 2022–2032

    16.1. Introduction

    16.2. Historical Market Size (US$ Mn) Analysis Trend Analysis By Market Taxonomy, 2012-2021

    16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032

        16.3.1. By Country

            16.3.1.1. China

            16.3.1.2. Japan

            16.3.1.3. South Korea

        16.3.2. By Tests Type

        16.3.3. By Infection Type

        16.3.4. By End User

    16.4. Market Attractiveness Analysis

        16.4.1. By Country

        16.4.2. By Tests Type

        16.4.3. By Infection Type

        16.4.4. By End User

    16.5. Market Trends

    16.6. Key Market Participants - Intensity Mapping

    16.7. Drivers and Restraints - Impact Analysis

    16.8. Country Level Analysis & Forecast

        16.8.1. China Anti-microbial/Anti-fungal Tests Market Analysis

            16.8.1.1. Introduction

            16.8.1.2. Market Analysis and Forecast by Market Taxonomy

                16.8.1.2.1. By Tests Type

                16.8.1.2.2. By Infection Type

                16.8.1.2.3. By End User

        16.8.2. Japan Anti-microbial/Anti-fungal Tests Market Analysis

            16.8.2.1. Introduction

            16.8.2.2. Market Analysis and Forecast by Market Taxonomy

                16.8.2.2.1. By Tests Type

                16.8.2.2.2. By Infection Type

                16.8.2.2.3. By End User

        16.8.3. South Korea Anti-microbial/Anti-fungal Tests Market Analysis

            16.8.3.1. Introduction

            16.8.3.2. Market Analysis and Forecast by Market Taxonomy

                16.8.3.2.1. By Tests Type

                16.8.3.2.2. By Infection Type

            16.8.3.3. By End User

17. Oceania Anti-microbial/Anti-fungal Tests Market 2017-2021 and Forecast 2022-2032

    17.1. Introduction

    17.2. Historical Market Size (US$ Mn) Analysis Trend Analysis By Market Taxonomy, 2012-2021

    17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2022–2032

        17.3.1. By Country

            17.3.1.1. Australia

            17.3.1.2. New Zealand

        17.3.2. By Tests Type

        17.3.3. By Infection Type

        17.3.4. By End User

    17.4. Market Attractiveness Analysis

        17.4.1. By Country

        17.4.2. By Tests Type

        17.4.3. By Infection Type

        17.4.4. By End User

    17.5. Market Trends

    17.6. Key Market Participants - Intensity Mapping

    17.7. Drivers and Restraints - Impact Analysis

    17.8. Country Level Analysis & Forecast

        17.8.1. Australia Anti-microbial/Anti-fungal Tests Market Analysis

            17.8.1.1. Introduction

            17.8.1.2. Market Analysis and Forecast by Market Taxonomy

                17.8.1.2.1. By Tests Type

                17.8.1.2.2. By Infection Type

                17.8.1.2.3. By End User

        17.8.2. New Zealand Anti-microbial/Anti-fungal Tests Market Analysis

            17.8.2.1. Introduction

            17.8.2.2. Market Analysis and Forecast by Market Taxonomy

                17.8.2.2.1. By Tests Type

                17.8.2.2.2. By Infection Type

                17.8.2.2.3. By End User

18. Middle East and Africa (MEA) Anti-microbial/Anti-fungal Tests Market Analysis 2012-2021 and Forecast 2022–2032

    18.1. Introduction

    18.2. Historical Market Size (US$ Mn) Analysis Trend Analysis By Market Taxonomy, 2012-2021

    18.3. Current and Future Market Size (US$ Mn) Analysis Forecast By Market Taxonomy, 2022–2032

        18.3.1. By Country

            18.3.1.1. GCC Countries

            18.3.1.2. Turkey

            18.3.1.3. South Africa

            18.3.1.4. North Africa

        18.3.2. By Tests Type

        18.3.3. By Infection Type

        18.3.4. By End User

    18.4. Market Attractiveness Analysis

        18.4.1. By Country

        18.4.2. By Tests Type

        18.4.3. By Infection Type

        18.4.4. By End User

    18.5. Market Trends

    18.6. Key Market Participants - Intensity Mapping

    18.7. Drivers and Restraints - Impact Analysis

    18.8. Country Level Analysis & Forecast

        18.8.1. GCC Countries Anti-microbial/Anti-fungal Tests Market Analysis

            18.8.1.1. Introduction

            18.8.1.2. Market Analysis and Forecast by Market Taxonomy

                18.8.1.2.1. By Tests Type

                18.8.1.2.2. By Infection Type

                18.8.1.2.3. By End User

        18.8.2. Turkey Anti-microbial/Anti-fungal Tests Market Analysis

            18.8.2.1. Introduction

            18.8.2.2. Market Analysis and Forecast by Market Taxonomy

                18.8.2.2.1. By Tests Type

                18.8.2.2.2. By Infection Type

                18.8.2.2.3. By End User

        18.8.3. South Africa Anti-microbial/Anti-fungal Tests Market Analysis

            18.8.3.1. Introduction

            18.8.3.2. Market Analysis and Forecast by Market Taxonomy

                18.8.3.2.1. By Tests Type

                18.8.3.2.2. By Infection Type

                18.8.3.2.3. By End User

        18.8.4. North Africa Anti-microbial/Anti-fungal Tests Market Analysis

            18.8.4.1. Introduction

            18.8.4.2. Market Analysis and Forecast by Market Taxonomy

                18.8.4.2.1. By Tests Type

                18.8.4.2.2. By Infection Type

                18.8.4.2.3. By End User

19. Market Structure Analysis

    19.1. Market Analysis by Tier of Companies

    19.2. Market Share Analysis of Top Players

    19.3. Market Presence Analysis

20. Competition Analysis

    20.1. Competition Dashboard

    20.2. Competition Benchmarking

    20.3. Competition Deep Dive

        20.3.1. Abbott Laboratories

            20.3.1.1. Overview

            20.3.1.2. Product Portfolio

            20.3.1.3. Fey Financials

            20.3.1.4. Sales Footprint

            20.3.1.5. Strategy Overview

        20.3.2. bioMérieux SA,

            20.3.2.1. Overview

            20.3.2.2. Product Portfolio

            20.3.2.3. Fey Financials

            20.3.2.4. Sales Footprint

            20.3.2.5. Strategy Overview

        20.3.3. Bio-Rad Laboratories Inc.,

            20.3.3.1. Overview

            20.3.3.2. Product Portfolio

            20.3.3.3. Fey Financials

            20.3.3.4. Sales Footprint

            20.3.3.5. Strategy Overview

        20.3.4. Bruker Corporation,

            20.3.4.1. Overview

            20.3.4.2. Product Portfolio

            20.3.4.3. Fey Financials

            20.3.4.4. Sales Footprint

            20.3.4.5. Strategy Overview

        20.3.5. Danaher Corporation,

            20.3.5.1. Overview

            20.3.5.2. Product Portfolio

            20.3.5.3. Fey Financials

            20.3.5.4. Sales Footprint

            20.3.5.5. Strategy Overview

        20.3.6. Erba Mannheim,

            20.3.6.1. Overview

            20.3.6.2. Product Portfolio

            20.3.6.3. Fey Financials

            20.3.6.4. Sales Footprint

            20.3.6.5. Strategy Overview

        20.3.7. F. Hoffmann-La Roche AG,

            20.3.7.1. Overview

            20.3.7.2. Product Portfolio

            20.3.7.3. Fey Financials

            20.3.7.4. Sales Footprint

            20.3.7.5. Strategy Overview

        20.3.8. Luminex Corporation,

            20.3.8.1. Overview

            20.3.8.2. Product Portfolio

            20.3.8.3. Fey Financials

            20.3.8.4. Sales Footprint

            20.3.8.5. Strategy Overview

        20.3.9. Meridian Bioscience Inc.,

            20.3.9.1. Overview

            20.3.9.2. Product Portfolio

            20.3.9.3. Fey Financials

            20.3.9.4. Sales Footprint

            20.3.9.5. Strategy Overview

        20.3.10. Norgen Biotek Corp.,

            20.3.10.1. Overview

            20.3.10.2. Product Portfolio

            20.3.10.3. Fey Financials

            20.3.10.4. Sales Footprint

            20.3.10.5. Strategy Overview

        20.3.11. Omega Diagnostics Group Plc.,

            20.3.11.1. Overview

            20.3.11.2. Product Portfolio

            20.3.11.3. Fey Financials

            20.3.11.4. Sales Footprint

            20.3.11.5. Strategy Overview

        20.3.12. Qiagen N.V.,

            20.3.12.1. Overview

            20.3.12.2. Product Portfolio

            20.3.12.3. Fey Financials

            20.3.12.4. Sales Footprint

            20.3.12.5. Strategy Overview

        20.3.13. Quidel Corporation,

            20.3.13.1. Overview

            20.3.13.2. Product Portfolio

            20.3.13.3. Fey Financials

            20.3.13.4. Sales Footprint

            20.3.13.5. Strategy Overview

        20.3.14. Thermo Fisher Scientific Inc.

            20.3.14.1. Overview

            20.3.14.2. Product Portfolio

            20.3.14.3. Fey Financials

            20.3.14.4. Sales Footprint

            20.3.14.5. Strategy Overview

21. Assumptions and Acronyms Used

22. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Anti-microbial / Anti-fungal Tests Market Analysis 2012–2021 and Forecast 2022–2032, by Test

Table 02: Global Anti-microbial / Anti-fungal Tests Market Analysis 2012–2021 and Forecast 2022–2032by Infection

Table 03: Global Anti-microbial / Anti-fungal Tests Market Analysis 2012–2021 and Forecast 2022–2032, by End User

Table 04: Global Anti-microbial / Anti-fungal Tests Market Analysis 2012–2021 and Forecast 2022–2032, by Region

Table 05: North America Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Country

Table 06: North America Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Test

Table 07: North America Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Infection

Table 08: North America Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by End User

Table 09: Latin America Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Country

Table 10: Latin America Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Test

Table 11: Latin America Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Infection

Table 12: Latin America Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by End User

Table 13: Europe Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Country

Table 14: Europe Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Test

Table 15: Europe Anti-microbial / Anti-fungal Tests Market Analysis 2012–2021 and Forecast 2022–2032by Infection

Table 16: Europe Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by End User

Table 17: East Asia Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Country

Table 18: East Asia Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Test

Table 19: East Asia Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Infection

Table 20: East Asia Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by End User

Table 21: South Asia Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Country

Table 22: South Asia Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Test

Table 23: South Asia Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Infection

Table 24: South Asia Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by End User

Table 25: Oceania Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Country

Table 26: Oceania Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Test

Table 27: Oceania Anti-microbial / Anti-fungal Tests Market Analysis 2012–2021 and Forecast 2022–2032by Infection

Table 28: Oceania Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by End User

Table 29: Middle East & Africa Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Country

Table 30: Middle East & Africa Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by Test

Table 31: Middle East & Africa Anti-microbial / Anti-fungal Tests Market Analysis 2012–2021 and Forecast 2022–2032by Infection

Table 32: Middle East & Africa Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis 2012–2021 and Forecast 2022–2032, by End User

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis, 2012–2021

Figure 02: Global Anti-microbial / Anti-fungal Tests Market Forecast & Y-o-Y Growth, 2022–2032

Figure 03: Global Anti-microbial / Anti-fungal Tests Market Absolute $ Opportunity (US$ Mn) Analysis, 2021–2032

Figure 04: Global Anti-microbial / Anti-fungal Tests Market Value Share (%) Analysis 2022 and 2032, by Test

Figure 05: Global Anti-microbial / Anti-fungal Tests Market Y-o-Y Growth (%) Analysis 2022-2032, by Test

Figure 06: Global Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis 2022–2032, by Test

Figure 07: Global Anti-microbial / Anti-fungal Tests Market Value Share (%) Analysis 2022 and 2032, by Infection

Figure 08: Global Anti-microbial / Anti-fungal Tests Market Y-o-Y Growth (%) Analysis 2022-2032, by Infection

Figure 09: Global Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis 2022–2032, by Infection

Figure 10: Global Anti-microbial / Anti-fungal Tests Market Value Share (%) Analysis 2022 and 2032, by End User

Figure 11: Global Anti-microbial / Anti-fungal Tests Market Y-o-Y Growth (%) Analysis 2022-2032, by End User

Figure 12: Global Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis 2022–2032, by End User

Figure 13: Global Anti-microbial / Anti-fungal Tests Market Value Share (%) Analysis 2022 and 2032, by Region

Figure 14: Global Anti-microbial / Anti-fungal Tests Market Y-o-Y Growth (%) Analysis 2022-2032, by Region

Figure 15: Global Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis 2022–2032, by Region

Figure 16: North America Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis, 2012–2021

Figure 17: North America Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Forecast, 2022-2032

Figure 18: North America Anti-microbial / Anti-fungal Tests Market Value Share, by Test (2022 E)

Figure 19: North America Anti-microbial / Anti-fungal Tests Market Value Share, by Infection (2022 E)

Figure 20: North America Anti-microbial / Anti-fungal Tests Market Value Share, by End User (2022 E)

Figure 21: North America Anti-microbial / Anti-fungal Tests Market Value Share, by Country (2022 E)

Figure 22: North America Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by Test, 2022–2032

Figure 23: North America Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by Infection, 2022–2032

Figure 24: North America Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by End User, 2022–2032

Figure 25: North America Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by Country, 2022–2032

Figure 26: U.S. Anti-microbial / Anti-fungal Tests Market Value Proportion Analysis, 2021

Figure 27: Global Vs. U.S. Growth Comparison, 2021-2032

Figure 28: U.S. Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Test, 2021 & 2032

Figure 29: U.S. Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Infection, 2021 & 2032

Figure 30: U.S. Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by End User, 2021 & 2032

Figure 31: Canada Anti-microbial / Anti-fungal Tests Market Value Proportion Analysis, 2021

Figure 32: Global Vs. Canada. Growth Comparison, 2021-2032

Figure 33: Canada Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Test, 2021 & 2032

Figure 34: Canada Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Infection, 2021 & 2032

Figure 35: Canada Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by End User, 2021 & 2032

Figure 36: Latin America Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis, 2012–2021

Figure 37: Latin America Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Forecast, 2022-2032

Figure 38: Latin America Anti-microbial / Anti-fungal Tests Market Value Share, by Test (2022 E)

Figure 39: Latin America Anti-microbial / Anti-fungal Tests Market Value Share, by Infection (2022 E)

Figure 40: Latin America Anti-microbial / Anti-fungal Tests Market Value Share, by End User (2022 E)

Figure 41: Latin America Anti-microbial / Anti-fungal Tests Market Value Share, by Country (2022 E)

Figure 42: Latin America Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by Test, 2022–2032

Figure 43: Latin America Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by Infection, 2022–2032

Figure 44: Latin America Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by End User, 2022–2032

Figure 45: Latin America Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by Country, 2022–2032

Figure 46: Mexico Anti-microbial / Anti-fungal Tests Market Value Proportion Analysis, 2021

Figure 47: Global Vs Mexico Growth Comparison, 2021-2032

Figure 48: Mexico Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Test, 2021 & 2032

Figure 49: Mexico Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Infection, 2021 & 2032

Figure 50: Mexico Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by End User, 2021 & 2032

Figure 51: Brazil Anti-microbial / Anti-fungal Tests Market Value Proportion Analysis, 2021

Figure 52: Global Vs. Brazil. Growth Comparison, 2021-2032

Figure 53: Brazil Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Test, 2021 & 2032

Figure 54: Brazil Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Infection, 2021 & 2032

Figure 55: Brazil Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by End User, 2021 & 2032

Figure 56: Argentina Anti-microbial / Anti-fungal Tests Market Value Proportion Analysis, 2021

Figure 57: Global Vs Argentina Growth Comparison, 2021-2032

Figure 58: Argentina Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Test, 2021 & 2032

Figure 59: Argentina Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Infection, 2021 & 2032

Figure 60: Argentina Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by End User, 2021 & 2032

Figure 61: Europe Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis, 2012–2021

Figure 62: Europe Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Forecast, 2022-2032

Figure 63: Europe Anti-microbial / Anti-fungal Tests Market Value Share, by Test (2022 E)

Figure 64: Europe Anti-microbial / Anti-fungal Tests Market Value Share, by Infection (2022 E)

Figure 65: Europe Anti-microbial / Anti-fungal Tests Market Value Share, by End User (2022 E)

Figure 66: Europe Anti-microbial / Anti-fungal Tests Market Value Share, by Country (2022 E)

Figure 67: Europe Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by Test, 2022–2032

Figure 68: Europe Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by Infection, 2022–2032

Figure 69: Europe Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by End User, 2022–2032

Figure 70: Europe Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by Country, 2022–2032

Figure 71: UK Anti-microbial / Anti-fungal Tests Market Value Proportion Analysis, 2021

Figure 72: Global Vs. UK Growth Comparison, 2021-2032

Figure 73: UK Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Test, 2021 & 2032

Figure 74: UK Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Infection, 2021 & 2032

Figure 75: UK Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by End User, 2021 & 2032

Figure 76: Germany Anti-microbial / Anti-fungal Tests Market Value Proportion Analysis, 2021

Figure 77: Global Vs. Germany Growth Comparison, 2021-2032

Figure 78: Germany Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Test, 2021 & 2032

Figure 79: Germany Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Infection, 2021 & 2032

Figure 80: Germany Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by End User, 2021 & 2032

Figure 81: Italy Anti-microbial / Anti-fungal Tests Market Value Proportion Analysis, 2021

Figure 82: Global Vs. Italy Growth Comparison, 2021-2032

Figure 83: Italy Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Test, 2021 & 2032

Figure 84: Italy Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Infection, 2021 & 2032

Figure 85: Italy Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by End User, 2021 & 2032

Figure 86: France Anti-microbial / Anti-fungal Tests Market Value Proportion Analysis, 2021

Figure 87: Global Vs France Growth Comparison, 2021-2032

Figure 88: France Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Test, 2021 & 2032

Figure 89: France Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Infection, 2021 & 2032

Figure 90: France Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by End User, 2021 & 2032

Figure 91: Spain Anti-microbial / Anti-fungal Tests Market Value Proportion Analysis, 2021

Figure 92: Global Vs Spain Growth Comparison, 2021-2032

Figure 93: Spain Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Test, 2021 & 2032

Figure 94: Spain Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Infection, 2021 & 2032

Figure 95: Spain Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by End User, 2021 & 2032

Figure 96: Russia Anti-microbial / Anti-fungal Tests Market Value Proportion Analysis, 2021

Figure 97: Global Vs Russia Growth Comparison, 2021-2032

Figure 98: Russia Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Test, 2021 & 2032

Figure 99: Russia Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Infection, 2021 & 2032

Figure 100: Russia Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by End User, 2021 & 2032

Figure 101: BENELUX Anti-microbial / Anti-fungal Tests Market Value Proportion Analysis, 2021

Figure 102: Global Vs BENELUX Growth Comparison, 2021-2032

Figure 103: BENELUX Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Test, 2021 & 2032

Figure 104: BENELUX Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Infection, 2021 & 2032

Figure 105: BENELUX Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by End User, 2021 & 2032

Figure 106: East Asia Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis, 2012–2021

Figure 107: East Asia Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Forecast, 2022-2032

Figure 108: East Asia Anti-microbial / Anti-fungal Tests Market Value Share, by Test (2022 E)

Figure 109: East Asia Anti-microbial / Anti-fungal Tests Market Value Share, by Infection (2022 E)

Figure 110: East Asia Anti-microbial / Anti-fungal Tests Market Value Share, by End User (2022 E)

Figure 111: East Asia Anti-microbial / Anti-fungal Tests Market Value Share, by Country (2022 E)

Figure 112: East Asia Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by Test, 2022–2032

Figure 113: East Asia Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by Infection, 2022–2032

Figure 114: East Asia Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by End User, 2022–2032

Figure 115: East Asia Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by Country, 2022–2032

Figure 116: China Anti-microbial / Anti-fungal Tests Market Value Proportion Analysis, 2021

Figure 117: Global Vs. China Growth Comparison, 2021-2032

Figure 118: China Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Test, 2021 & 2032

Figure 119: China Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Infection, 2021 & 2032

Figure 120: China Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by End User, 2021 & 2032

Figure 121: Japan Anti-microbial / Anti-fungal Tests Market Value Proportion Analysis, 2021

Figure 122: Global Vs. Japan Growth Comparison, 2021-2032

Figure 123: Japan Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Test, 2021 & 2032

Figure 124: Japan Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Infection, 2021 & 2032

Figure 125: Japan Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by End User, 2021 & 2032

Figure 126: South Korea Anti-microbial / Anti-fungal Tests Market Value Proportion Analysis, 2021

Figure 127: Global Vs South Korea Growth Comparison, 2021-2032

Figure 128: South Korea Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Test, 2021 & 2032

Figure 129: South Korea Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Infection, 2021 & 2032

Figure 130: South Korea Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by End User, 2021 & 2032

Figure 131: South Asia Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis, 2012–2021

Figure 132: South Asia Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Forecast, 2022-2032

Figure 133: South Asia Anti-microbial / Anti-fungal Tests Market Value Share, by Test (2022 E)

Figure 134: South Asia Anti-microbial / Anti-fungal Tests Market Value Share, by Infection (2022 E)

Figure 135: South Asia Anti-microbial / Anti-fungal Tests Market Value Share, by End User (2022 E)

Figure 136: South Asia Anti-microbial / Anti-fungal Tests Market Value Share, by Country (2022 E)

Figure 137: South Asia Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by Test, 2022–2032

Figure 138: South Asia Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by Infection, 2022–2032

Figure 139: South Asia Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by End User, 2022–2032

Figure 140: South Asia Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by Country, 2022–2032

Figure 141: India Anti-microbial / Anti-fungal Tests Market Value Proportion Analysis, 2021

Figure 142: Global Vs. India Growth Comparison, 2021-2032

Figure 143: India Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Test, 2021 & 2032

Figure 144: India Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Infection, 2021 & 2032

Figure 145: India Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by End User, 2021 & 2032

Figure 146: Indonesia Anti-microbial / Anti-fungal Tests Market Value Proportion Analysis, 2021

Figure 147: Global Vs. Indonesia Growth Comparison, 2021-2032

Figure 148: Indonesia Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Test, 2021 & 2032

Figure 149: Indonesia Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Infection, 2021 & 2032

Figure 150: Indonesia Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by End User, 2021 & 2032

Figure 151: Malaysia Anti-microbial / Anti-fungal Tests Market Value Proportion Analysis, 2021

Figure 152: Global Vs. Malaysia Growth Comparison, 2021-2032

Figure 153: Malaysia Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Test, 2021 & 2032

Figure 154: Malaysia Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Infection, 2021 & 2032

Figure 155: Malaysia Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by End User, 2021 & 2032

Figure 156: Thailand Anti-microbial / Anti-fungal Tests Market Value Proportion Analysis, 2021

Figure 157: Global Vs. Thailand Growth Comparison, 2021-2032

Figure 158: Thailand Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Test, 2021 & 2032

Figure 159: Thailand Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Infection, 2021 & 2032

Figure 160: Thailand Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by End User, 2021 & 2032

Figure 161: Oceania Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis, 2012–2021

Figure 162: Oceania Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Forecast, 2022-2032

Figure 163: Oceania Anti-microbial / Anti-fungal Tests Market Value Share, by Test (2022 E)

Figure 164: Oceania Anti-microbial / Anti-fungal Tests Market Value Share, by Infection (2022 E)

Figure 165: Oceania Anti-microbial / Anti-fungal Tests Market Value Share, by End User (2022 E)

Figure 166: Oceania Anti-microbial / Anti-fungal Tests Market Value Share, by Country (2022 E)

Figure 167: Oceania Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by Test, 2022–2032

Figure 168: Oceania Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by Infection, 2022–2032

Figure 169: Oceania Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by End User, 2022–2032

Figure 170: Oceania Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by Country, 2022–2032

Figure 171: Australia Anti-microbial / Anti-fungal Tests Market Value Proportion Analysis, 2021

Figure 172: Global Vs. Australia Growth Comparison, 2021-2032

Figure 173: Australia Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Test, 2021 & 2032

Figure 174: Australia Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Infection, 2021 & 2032

Figure 175: Australia Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by End User, 2021 & 2032

Figure 176: New Zealand Anti-microbial / Anti-fungal Tests Market Value Proportion Analysis, 2021

Figure 177: Global Vs New Zealand Growth Comparison, 2021-2032

Figure 178: New Zealand Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Test, 2021 & 2032

Figure 179: New Zealand Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Infection, 2021 & 2032

Figure 180: New Zealand Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by End User, 2021 & 2032

Figure 181: Middle East & Africa Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Analysis, 2012–2021

Figure 182: Middle East & Africa Anti-microbial / Anti-fungal Tests Market Value (US$ Mn) Forecast, 2022-2032

Figure 183: Middle East & Africa Anti-microbial / Anti-fungal Tests Market Value Share, by Test (2022 E)

Figure 184: Middle East & Africa Anti-microbial / Anti-fungal Tests Market Value Share, by Infection (2022 E)

Figure 185: Middle East & Africa Anti-microbial / Anti-fungal Tests Market Value Share, by End User (2022 E)

Figure 186: Middle East & Africa Anti-microbial / Anti-fungal Tests Market Value Share, by Country (2022 E)

Figure 187: Middle East & Africa Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by Test, 2022–2032

Figure 188: Middle East & Africa Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by Infection, 2022–2032

Figure 189: Middle East & Africa Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by End User, 2022–2032

Figure 190: Middle East & Africa Anti-microbial / Anti-fungal Tests Market Attractiveness Analysis by Country, 2022–2032

Figure 191: GCC Countries Anti-microbial / Anti-fungal Tests Market Value Proportion Analysis, 2021

Figure 192: Global Vs GCC Countries Growth Comparison, 2021-2032

Figure 193: GCC Countries Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Test, 2021 & 2032

Figure 194: GCC Countries Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Infection, 2021 & 2032

Figure 195: GCC Countries Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by End User, 2021 & 2032

Figure 196: Turkey Anti-microbial / Anti-fungal Tests Market Value Proportion Analysis, 2021

Figure 197: Global Vs. Turkey Growth Comparison, 2021-2032

Figure 198: Turkey Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Test, 2021 & 2032

Figure 199: Turkey Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Infection, 2021 & 2032

Figure 200: Turkey Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by End User, 2021 & 2032

Figure 201: South Africa Anti-microbial / Anti-fungal Tests Market Value Proportion Analysis, 2021

Figure 202: Global Vs. South Africa Growth Comparison, 2021-2032

Figure 203: South Africa Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Test, 2021 & 2032

Figure 204: South Africa Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Infection, 2021 & 2032

Figure 205: South Africa Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by End User, 2021 & 2032

Figure 206: North Africa Anti-microbial / Anti-fungal Tests Market Value Proportion Analysis, 2021

Figure 207: Global Vs North Africa Growth Comparison, 2021-2032

Figure 208: North Africa Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Test, 2021 & 2032

Figure 209: North Africa Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by Infection, 2021 & 2032

Figure 210: North Africa Anti-microbial / Anti-fungal Tests Market Share Analysis (%) by End User, 2021 & 2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Fungal Testing Kits Market

Published : September 2020

Healthcare

At-Home Vaginal pH Test Kit Market

Published : January 2019

Healthcare

Fungal Keratitis Treatment Market

Published : June 2018

Healthcare

Fertility and Pregnancy Rapid Test Kits Market

Published : February 2022

Google translate

Anti-microbial/Anti-fungal Tests Market